Navigation Links
WaferGen to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
Date:11/4/2008

FREMONT, Calif., Nov. 4 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene expression, genotyping, cell biology and stem cell research systems, today announced that Alnoor Shivji, WaferGen's president and chief executive officer, will deliver a corporate presentation at Rodman & Renshaw's 10th Annual Healthcare Conference. The conference will be held November 10-12, 2008, at the New York Palace Hotel in New York.

WaferGen's presentation will take place at 3:40 p.m. (EST) on Monday, November 10, 2008. The presentation will include an overview of the company's SmartChip(TM) Real-Time PCR System, which is currently being developed for the gene expression and genotyping markets, and the SmartSlide(TM) Micro- Incubation System that WaferGen is actively marketing. A live webcast and 90- day archived presentation can be accessed at http://www.wafergen.com.

About WaferGen

WaferGen Biosystems, Inc. is a leader in the development, manufacture and sale of state-of-the-art systems for gene expression, genotyping, cell biology and stem cell research for the life science and pharmaceutical industries. The company is actively developing its SmartChip(TM) product for the gene expression and genotyping markets. SmartChip is being developed as the first whole genome, high throughput gene expression real-time polymerase chain reaction (PCR) platform. This innovative system, combined with next-generation chemistry and optimized assays being developed by WaferGen, promises to deliver significant speed and cost advantages to researchers in the gene expression and genotyping markets. Based on collaborations established with leading research institutions, WaferGen believes that the SmartChip Real-Time PCR System is positioned as the platform of choice for biomarker discovery and validation. WaferGen currently markets its SmartSlide(TM) fa
'/>"/>

SOURCE WaferGen Biosystems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. NIH Awards Approximately $3M Grant for Research Involving WaferGens SmartChip(TM) Real-Time PCR System at the University of Pittsburgh
2. WaferGen to Present at the Seventh Annual BIO Investor Forum
3. WaferGen Announces Second Quarter 2008 Financial Results
4. WaferGen to Present at the Ninth Annual Beyond Genome Conference
5. WaferGen Announces Signing of Two Private Placements
6. WaferGen to Present at the Rodman and Renshaw Fifth Annual Global Healthcare Conference
7. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in Germany
8. WaferGen Signs Exclusive Distribution Agreement for SmartSlide(TM) Micro-Incubation System in United Kingdom and France
9. WaferGen to Present at the Cambridge Health Institutes Fifth Annual Molecular Diagnostics Partnerships in Personalized Medicine Conference
10. WaferGen Announces Management Team Promotions
11. WaferGen to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... DUBLIN , Sep. 02, 2015 ... ) has announced the addition of Jain PharmaBiotech,s ... Markets and Companies" to their offering. ... markets based on technologies and applications. The report ... basis for estimation of markets. Technologies include array ...
(Date:9/2/2015)... 02, 2015 ... announced the addition of Jain PharmaBiotech,s new ... Companies" to their offering. ... besides fluorescence in situ hybridization (FISH), comparative ... cytogenetics includes application of nanobiotechnology, microarrays, real-time ...
(Date:9/2/2015)... , Sept. 2, 2015 Australian prostate ... a prestigious Australian science prize recognising ,outstanding, science that ... track to globally launch a novel prostate cancer diagnostic ... a high level consortium taking out the peer-reviewed Australian ... Scientific Research. This prize is awarded ...
(Date:9/2/2015)... ZIONA, Israel , September 2, ... TASE: BVXV) today announced the intent of the National Institute ... National Institutes of Health (NIH) within the Department of Health ... trial to be held in the United States ... the use of BiondVax,s universal flu vaccine candidate, Multimeric-001 (M-001), ...
Breaking Biology Technology:Global Biochips and Microarrays Technologies, Markets and Companies Report 2015 with Market Size in 2014 and Projected Value for the Years 2019 and 2024 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 2Global Cytogenetics Technologies Study 2015-2025 - Latest Markets and Companies Analysis 3Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3
... Oct. 29 MannKind,Corporation (Nasdaq: MNKD ) will ... 5, 2008 at 8:00 a.m. EST., Management of ... the,third quarter financial results, clinical progress and other Company,developments ... from the,Company will be its Chairman and Chief Executive ...
... (Nasdaq: SGMO ) today reported third quarter 2008,financial ... September 30, 2008, Sangamo reported a,consolidated net loss of ... loss of $4.3 million, or $0.11 per share, for ... the company had cash, cash equivalents and,investments of $59.5 ...
... Pharmaceuticals Inc.,(Nasdaq: TRBN ) today announced that executives ... at two upcoming industry and/or investor,conferences:, -- Nov. ... the,New York Palace Hotel, 455 Madison Ave. in New ... president, is scheduled to present,at 9:55 a.m. EST., ...
Cached Biology Technology:MannKind Corporation to Hold Third Quarter Financial Results Conference Call on November 5, 2008 2Sangamo BioSciences Reports Third Quarter 2008 Financial Results 2Sangamo BioSciences Reports Third Quarter 2008 Financial Results 3Sangamo BioSciences Reports Third Quarter 2008 Financial Results 4Sangamo BioSciences Reports Third Quarter 2008 Financial Results 5Sangamo BioSciences Reports Third Quarter 2008 Financial Results 6Sangamo BioSciences Reports Third Quarter 2008 Financial Results 7Trubion Announces Presentations at Upcoming Investor Conferences 2
(Date:8/6/2015)... 2015  Today, U.S. Congressman Mike Honda ... to learn firsthand how Silicon Valley technologies can ... a world leader in multi-factor identity management and ... federal agencies and commercial organizations achieve new levels ... "The vast majority of network breaches can be ...
(Date:8/5/2015)... August 5, 2015 According to ... Management Market by Software, Services, Vertical (BFSI, Airport, IT & ... - Global Forecast to 2020", published by MarketsandMarkets, defines ... globally into various segments. The global PIAM Market is ... $546.2 Million by 2019, at a CAGR of 14.9 ...
(Date:8/4/2015)... 2015 Research ... the addition of the "Digital Forensics ... Sub-Segment (Computer Forensics, Network Forensics, Mobile Device ... Vertical and Region - Global Forecast to ... By Component (Hardware, Software, and Service), ...
Breaking Biology News(10 mins):Rep. Honda to Visit Crossmatch in Redwood City 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
... gene they suspect plays an important role in triggering ... century-and-a-half ago. , And the pathogen that contains this ... the modern world?on the order of billions of dollars ... Avr3a, in a study that appears online in the ...
... Created as an alternate route of drug administration to ... skin patches are rapidly becoming an important healthcare product ... of chronic conditions such as angina, hypertension and HRT, ... transdermal patches for a host of new conditions wind ...
... Microarray technology can be used to identify each stage ... newly published report. , Melanomas grow in two phases: ... metastasize (spread cancer to other parts of the body) ... a large primary melanoma into radial and vertical portions, ...
Cached Biology News:Researchers find gene that may be at root of potato blight 2Researchers find gene that may be at root of potato blight 3
... ISO 9001:2000 Certified USDA Research Registered OLAW ... Training AALAS Certified Technicians ... GLP Documentation Upon Request Focus ... for all your custom immunology service needs. ...
biotin-4-fluorescein...
Human IL-17D Affinity Purified Polyclonal Ab...
Agar, 5 lb. Bacteriological.Moisture: < 10%, ash: < 6.5%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: